STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 15.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $16,000 | -73.8% | 3,238 | -43.2% | 0.00% | – |
| Q4 2019 | $61,000 | +96.8% | 5,699 | +90.0% | 0.00% | – |
| Q3 2019 | $31,000 | -34.0% | 3,000 | -1.5% | 0.00% | – |
| Q2 2019 | $47,000 | +20.5% | 3,047 | +1.4% | 0.00% | – |
| Q1 2019 | $39,000 | +34.5% | 3,004 | +0.1% | 0.00% | – |
| Q4 2018 | $29,000 | -53.2% | 3,000 | -20.3% | 0.00% | – |
| Q3 2018 | $62,000 | +24.0% | 3,766 | +19.8% | 0.00% | – |
| Q2 2018 | $50,000 | +8.7% | 3,144 | +4.7% | 0.00% | – |
| Q1 2018 | $46,000 | -16.4% | 3,003 | -14.2% | 0.00% | – |
| Q4 2017 | $55,000 | -1.8% | 3,500 | -31.2% | 0.00% | – |
| Q3 2017 | $56,000 | +93.1% | 5,089 | +63.9% | 0.00% | – |
| Q2 2017 | $29,000 | -9.4% | 3,104 | -17.2% | 0.00% | – |
| Q1 2017 | $32,000 | -25.6% | 3,747 | -6.0% | 0.00% | – |
| Q4 2016 | $43,000 | – | 3,985 | +6030.8% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 65 | -90.4% | 0.00% | – |
| Q3 2015 | $6,000 | -40.0% | 679 | -23.9% | 0.00% | – |
| Q2 2015 | $10,000 | – | 892 | +11050.0% | 0.00% | – |
| Q4 2014 | $0 | -100.0% | 8 | -85.5% | 0.00% | – |
| Q3 2013 | $2,000 | – | 55 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|